Par Drugs and Chemicals Ltd
NSE:PAR
Par Drugs and Chemicals Ltd
NSE:PAR
Price:
90.47
INR
-1.7%
Market Closed
Market Cap:
₹1.1B
Balance Sheet
Balance Sheet Decomposition
Par Drugs and Chemicals Ltd
Par Drugs and Chemicals Ltd
Balance Sheet Decomposition is not available for
Par Drugs and Chemicals Ltd
Par Drugs and Chemicals Ltd
Balance Sheet
Par Drugs and Chemicals Ltd
Par Drugs and Chemicals Ltd
Currency: INR
| Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
1
|
0
|
20
|
212
|
162
|
222
|
335
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
335
|
0
|
|
| Cash Equivalents |
0
|
1
|
0
|
20
|
212
|
162
|
222
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
30
|
31
|
205
|
|
| Total Receivables |
94
|
99
|
98
|
139
|
125
|
217
|
212
|
185
|
211
|
|
| Accounts Receivables |
81
|
87
|
85
|
124
|
125
|
185
|
170
|
137
|
167
|
|
| Other Receivables |
13
|
11
|
13
|
15
|
0
|
33
|
42
|
48
|
43
|
|
| Inventory |
40
|
41
|
43
|
29
|
30
|
47
|
60
|
44
|
62
|
|
| Other Current Assets |
1
|
0
|
0
|
1
|
45
|
9
|
7
|
0
|
0
|
|
| Total Current Assets |
136
|
140
|
142
|
242
|
412
|
436
|
494
|
596
|
549
|
|
| PP&E Net |
415
|
390
|
363
|
351
|
344
|
344
|
387
|
413
|
389
|
|
| PP&E Gross |
415
|
390
|
363
|
351
|
0
|
0
|
387
|
413
|
389
|
|
| Accumulated Depreciation |
142
|
173
|
175
|
198
|
0
|
0
|
291
|
325
|
362
|
|
| Note Receivable |
9
|
8
|
7
|
7
|
0
|
0
|
2
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
251
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
8
|
8
|
6
|
6
|
5
|
|
| Total Assets |
560
N/A
|
539
-4%
|
513
-5%
|
601
+17%
|
764
+27%
|
787
+3%
|
889
+13%
|
1 016
+14%
|
1 194
+17%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
78
|
53
|
49
|
62
|
67
|
107
|
81
|
54
|
109
|
|
| Short-Term Debt |
65
|
51
|
43
|
0
|
32
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
40
|
50
|
12
|
14
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
13
|
14
|
20
|
32
|
60
|
42
|
59
|
71
|
57
|
|
| Total Current Liabilities |
196
|
167
|
125
|
108
|
160
|
149
|
140
|
124
|
166
|
|
| Long-Term Debt |
143
|
131
|
60
|
46
|
44
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
27
|
32
|
34
|
37
|
34
|
36
|
35
|
35
|
36
|
|
| Other Liabilities |
2
|
3
|
3
|
4
|
4
|
4
|
1
|
0
|
3
|
|
| Total Liabilities |
368
N/A
|
332
-10%
|
222
-33%
|
195
-12%
|
242
+24%
|
188
-22%
|
176
-6%
|
160
-9%
|
204
+28%
|
|
| Equity | ||||||||||
| Common Stock |
85
|
85
|
45
|
62
|
62
|
123
|
123
|
123
|
123
|
|
| Retained Earnings |
108
|
122
|
146
|
176
|
461
|
476
|
483
|
627
|
760
|
|
| Additional Paid In Capital |
0
|
0
|
100
|
168
|
0
|
0
|
107
|
107
|
107
|
|
| Total Equity |
192
N/A
|
207
+8%
|
290
+40%
|
406
+40%
|
522
+29%
|
599
+15%
|
712
+19%
|
856
+20%
|
990
+16%
|
|
| Total Liabilities & Equity |
560
N/A
|
539
-4%
|
513
-5%
|
601
+17%
|
764
+27%
|
787
+3%
|
889
+13%
|
1 016
+14%
|
1 194
+17%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
3
|
3
|
4
|
6
|
6
|
12
|
12
|
12
|
12
|
|
| Preferred Shares Outstanding |
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
